Vanderbilt University School of Medicine, Nashville, TN.
Vanderbilt University Medical Center, Department of Cardiac Surgery, Nashville, TN.
J Cardiothorac Vasc Anesth. 2024 Dec;38(12):2965-2972. doi: 10.1053/j.jvca.2024.09.014. Epub 2024 Sep 19.
This study was designed to explore key safety outcomes after operating room (OR) extubation in minimally invasive cardiac valve surgery.
Single-center retrospective chart review.
Academic medical center in the United States.
Patients undergoing valvular surgery via thoracotomy (November 2017-October 2022) at a single institution.
The OR extubation protocol was implemented on August 20, 2020.
Delirium rates, reintubation rates, and intubation duration were compared before and after OR extubation protocol implementation. Logistic regression identified patient perioperative characteristics associated with unsuccessful OR extubation. Among 312 patients, 254 were extubated in the intensive care unit (ICU) and 58 in the OR. Preoperative demographics were comparable except for the Charlson Comorbidity Index (median: 2.0 ICU extubation v 1.5 OR extubation). Interrupted time series analysis showed no change in postoperative delirium post-OR extubation implementation, with a trend toward decreasing delirium (risk ratio = 0.37, CI: 0.13-1.10, p = 0.07). The postimplementation era also had a lower median intubation duration (8 hours v 13 hours, p < 0.001) without increasing reintubation rates (1.7% v 7.9%, p = 0.159). Increased bypass length (odds ratio = 0.99, CI: 0.98-0.99, p < 0.001), intraoperative morphine milligram equivalents (odds ratio = 0.99, CI: 0.99-1.0, p = 0.009), and preoperative Charlson Comorbidity Index above 3 (odds ratio = 0.42, CI: 0.19-0.95, p = 0.037) were associated with decreased odds of OR extubation.
OR extubation was not associated with increased postoperative delirium or reintubation rates but did decrease intubation duration. Successful OR extubation relies upon the consideration of various patient perioperative characteristics.
本研究旨在探讨微创心脏瓣膜手术后手术室(OR)拔管后的关键安全结局。
单中心回顾性图表回顾。
美国学术医疗中心。
在一家机构接受经胸微创瓣膜手术的患者(2017 年 11 月至 2022 年 10 月)。
OR 拔管方案于 2020 年 8 月 20 日实施。
比较了 OR 拔管方案实施前后的谵妄发生率、再插管率和插管时间。逻辑回归确定了与 OR 拔管失败相关的患者围手术期特征。在 312 名患者中,254 名在重症监护病房(ICU)拔管,58 名在 OR 拔管。术前人口统计学特征相似,除了 Charlson 合并症指数(中位数:ICU 拔管 2.0,OR 拔管 1.5)。中断时间序列分析显示,OR 拔管实施后术后谵妄无变化,谵妄呈下降趋势(风险比=0.37,CI:0.13-1.10,p=0.07)。后实施时代的中位插管时间也较短(8 小时比 13 小时,p<0.001),但再插管率没有增加(1.7%比 7.9%,p=0.159)。更长的体外循环时间(比值比=0.99,CI:0.98-0.99,p<0.001)、术中吗啡毫克当量(比值比=0.99,CI:0.99-1.0,p=0.009)和术前 Charlson 合并症指数大于 3(比值比=0.42,CI:0.19-0.95,p=0.037)与 OR 拔管的可能性降低相关。
OR 拔管与术后谵妄或再插管率增加无关,但确实缩短了插管时间。成功的 OR 拔管依赖于考虑各种患者围手术期特征。